Cerity Partners’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.1M | Sell |
95,497
-31,710
| -25% | -$8.77M | 0.03% | 467 |
|
|
2026
Q1 | $37.6M | Sell |
127,207
-10,182
| -7% | -$3.02M | 0.05% | 295 |
|
|
2025
Q4 | $37.5M | Buy |
137,389
+10,062
| +8% | +$2.73M | 0.05% | 284 |
|
|
2025
Q3 | $34.4M | Buy |
127,327
+2,167
| +2% | +$590K | 0.06% | 267 |
|
|
2025
Q2 | $34.5M | Sell |
125,160
-48,966
| -28% | -$13.3M | 0.06% | 251 |
|
|
2025
Q1 | $46.2M | Buy |
174,126
+91,112
| +110% | +$22.5M | 0.09% | 196 |
|
|
2024
Q4 | $18.9M | Buy |
83,014
+10,097
| +14% | +$2.32M | 0.04% | 321 |
|
|
2024
Q3 | $16.1M | Buy |
72,917
+27,332
| +60% | +$5.66M | 0.04% | 365 |
|
|
2024
Q2 | $8.96M | Sell |
45,585
-11,266
| -20% | -$2.33M | 0.02% | 451 |
|
|
2024
Q1 | $12.2M | Buy |
56,851
+35,264
| +163% | +$7.41M | 0.03% | 398 |
|
|
2023
Q4 | $4.55M | Buy |
21,587
+15,777
| +272% | +$3.37M | 0.01% | 561 |
|
|
2023
Q3 | $1.16M | Sell |
5,810
-19,687
| -77% | -$3.91M | 0.01% | 714 |
|
|
2023
Q2 | $4.72M | Buy |
25,497
+1,092
| +4% | +$202K | 0.02% | 508 |
|
|
2023
Q1 | $5.68M | Buy |
24,405
+1,389
| +6% | +$251K | 0.01% | 467 |
|
|
2022
Q4 | $3.87M | Buy |
23,016
+117
| +0.5% | +$20.3K | 0.02% | 404 |
|
|
2022
Q3 | $4.06M | Buy |
22,899
+33
| +0.1% | +$6.52K | 0.05% | 269 |
|
|
2022
Q2 | $4.68M | Buy |
22,866
+1,993
| +10% | +$422K | 0.05% | 255 |
|
|
2022
Q1 | $4.96M | Buy |
20,873
+9,584
| +85% | +$2.25M | 0.08% | 195 |
|
|
2021
Q4 | $2.58M | Sell |
11,289
-11,274
| -50% | -$2.48M | 0.04% | 281 |
|
|
2021
Q3 | $4.36M | Buy |
22,563
+3,099
| +16% | +$628K | 0.1% | 174 |
|
|
2021
Q2 | $4.14M | Sell |
19,464
-189
| -1% | -$39.9K | 0.09% | 173 |
|
|
2021
Q1 | $4.01M | Sell |
19,653
-2,548
| -11% | -$502K | 0.1% | 169 |
|
|
2020
Q4 | $4.04M | Sell |
22,201
-1,213
| -5% | -$206K | 0.13% | 136 |
|
|
2020
Q3 | $3.92M | Buy |
23,414
+17,255
| +280% | +$2.91M | 0.16% | 113 |
|
|
2020
Q2 | $1M | Buy |
6,159
+312
| +5% | +$55.9K | 0.06% | 202 |
|
|
2020
Q1 | $1.01M | Buy |
5,847
+1,939
| +50% | +$386K | 0.06% | 203 |
|
|
2019
Q4 | $784K | Sell |
3,908
-10,545
| -73% | -$2.16M | 0.04% | 272 |
|
|
2019
Q3 | $3.05M | Buy |
14,453
+9,677
| +203% | +$2.02M | 0.18% | 123 |
|
|
2019
Q2 | $927K | Sell |
4,776
-3,795
| -44% | -$700K | 0.06% | 242 |
|
|
2019
Q1 | $1.41M | Sell |
8,571
-7,013
| -45% | -$1.24M | 0.1% | 198 |
|
|
2018
Q4 | $2.93M | Buy |
15,584
+3,349
| +27% | +$618K | 0.2% | 117 |
|
|
2018
Q3 | $2.08M | Buy |
12,235
+685
| +6% | +$115K | 0.14% | 159 |
|
|
2018
Q2 | $1.89M | Buy |
11,550
+9,021
| +357% | +$1.47M | 0.14% | 161 |
|
|
2018
Q1 | $409K | Buy |
2,529
+20
| +0.8% | +$3.18K | 0.03% | 374 |
|
|
2017
Q4 | $366K | Buy |
+2,509
| New | +$357K | 0.02% | 395 |
|
|
2017
Q2 | – | Sell |
-1,784
| Closed | -$212K | – | 355 |
|
|
2017
Q1 | $212K | Buy |
+1,784
| New | +$215K | 0.02% | 408 |
|
Other funds holding CME
VCM
VPM
Cerity Partners's CME Position: Q2 2026 in Review
Cerity Partners reduced its CME Group (CME) stake by 25% in Q2 2026, selling an estimated $8.77M and leaving 95,497 shares worth $21.1M. The position accounts for 0.03% of the portfolio, ranked #467.
Cerity Partners first reported a position in CME in Q1 2017 and has held it in 36 quarters since. The position peaked at $46.2M in Q1 2025. 1,602 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Cerity Partners held 95,497 shares of CME Group worth $21.1M as of Q2 2026.
- Cerity Partners sold 31,710 CME Group shares in Q2 2026, an estimated $8.77M.
- CME Group made up 0.03% of Cerity Partners's portfolio in Q2 2026, its #467 holding.
- Cerity Partners first reported a position in CME Group in Q1 2017 and has held it in 36 quarters since.
- Cerity Partners's CME Group position peaked at $46.2M in Q1 2025.
- 1,602 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.